Literature DB >> 27859927

Clinical features of familial amyloid polyneuropathy carrying transthyretin mutations in four Chinese kindreds.

Gonglu Liu1, Wang Ni1, Hongxia Wang2, Hongfu Li1, Yue Zhang3, Ning Wang4, Zhiying Wu1.   

Abstract

Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) is a rare hereditary disorder, characterized by a length-dependent polyneuropathy and dysfunction of various organs. Wide phenotypic heterogeneity makes early diagnosis difficult. In this study, we reviewed the clinical and electrophysiological features of four unrelated Chinese families with genetically confirmed TTR-FAP. Sequence analysis of TTR gene revealed the presence of four different mutations: Thr49Ala(p.Thr69Ala), Leu55Arg(p.Leu75Arg), Tyr116Ser(p.Tyr136Ser), and Ala36Pro(p.Ala56Pro) from six affected patients and two asymptomatic individuals. Two mutations, Thr49Ala(p.Thr69Ala) and Tyr116Ser(p.Tyr136 Ser), were detected in Chinese FAP patients for the first time. All affected patients manifested a progressive sensorimotor polyneuropathy starting in the lower limbs. The majority of the examined patients displayed cardiomyopathy and vitreous opacities. To avoid misdiagnosis, clinicians should consider screening for TTR variants in patients presenting with progressive polyneuropathy of undetermined origins.
© 2016 Peripheral Nerve Society.

Entities:  

Keywords:  Chinese; TTR; cardiomyopathy; sensorimotor polyneuropathy; vitreous opacities

Mesh:

Substances:

Year:  2017        PMID: 27859927     DOI: 10.1111/jns.12196

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  7 in total

Review 1.  Transthyretin familial amyloid polyneuropathy: an update.

Authors:  Violaine Plante-Bordeneuve
Journal:  J Neurol       Date:  2017-12-16       Impact factor: 4.849

2.  Single AAV-mediated CRISPR-Nme2Cas9 efficiently reduces mutant hTTR expression in a transgenic mouse model of transthyretin amyloidosis.

Authors:  Jinkun Wen; Tianqi Cao; Jinni Wu; Yuxi Chen; Shengyao Zhi; Yanming Huang; Peilin Zhen; Guanglan Wu; Lars Aagaard; Jianxin Zhong; Puping Liang; Junjiu Huang
Journal:  Mol Ther       Date:  2021-05-14       Impact factor: 11.454

3.  Characteristics of South Korean Patients with Hereditary Transthyretin Amyloidosis.

Authors:  Kyomin Choi; Jin Myoung Seok; Byoung Joon Kim; Young Cheol Choi; Ha Young Shin; Il Nam Sunwoo; Dae Seong Kim; Jung Joon Sung; Ga Yeon Lee; Eun Seok Jeon; Nam Hee Kim; Ju Hong Min; Jeeyoung Oh
Journal:  J Clin Neurol       Date:  2018-10       Impact factor: 3.077

Review 4.  Diagnosis and treatment of urinary and sexual dysfunction in hereditary TTR amyloidosis.

Authors:  Imad Bentellis; Gérard Amarenco; Xavier Gamé; Dora Jericevic; Mehdi El-Akri; Caroline Voiry; Lucas Freton; Juliette Hascoet; Quentin Alimi; Jacques Kerdraon; Benjamin M Brucker; Benoit Peyronnet
Journal:  Clin Auton Res       Date:  2019-08-26       Impact factor: 4.435

5.  Hereditary transthyretin amyloidosis in mainland China: a unicentric retrospective study.

Authors:  Kang Du; Fan Li; Hui Wang; Yuanfeng Miao; He Lv; Wei Zhang; Zhaoxia Wang; Yun Yuan; Lingchao Meng
Journal:  Ann Clin Transl Neurol       Date:  2021-03-19       Impact factor: 4.511

6.  Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China.

Authors:  Xinyue He; Zhuang Tian; Hongzhi Guan; Shuyang Zhang
Journal:  Orphanet J Rare Dis       Date:  2022-09-02       Impact factor: 4.303

7.  Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy.

Authors:  Shan He; Zhuang Tian; Hongzhi Guan; Jian Li; Quan Fang; Shuyang Zhang
Journal:  Orphanet J Rare Dis       Date:  2019-11-12       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.